Does RAMUCIRUMAB Cause Carcinoembryonic antigen increased? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Carcinoembryonic antigen increased have been filed in association with RAMUCIRUMAB (CYRAMZA). This represents 0.2% of all adverse event reports for RAMUCIRUMAB.
11
Reports of Carcinoembryonic antigen increased with RAMUCIRUMAB
0.2%
of all RAMUCIRUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From RAMUCIRUMAB?
Of the 11 reports, 4 (36.4%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAMUCIRUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does RAMUCIRUMAB Cause?
Malignant neoplasm progression (743)
Death (492)
Interstitial lung disease (269)
Febrile neutropenia (229)
Neutropenia (229)
Decreased appetite (187)
Diarrhoea (186)
Hypertension (175)
Pyrexia (161)
Nausea (160)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which RAMUCIRUMAB Alternatives Have Lower Carcinoembryonic antigen increased Risk?
RAMUCIRUMAB vs RANEXA
RAMUCIRUMAB vs RANIBIZUMAB
RAMUCIRUMAB vs RANIMUSTINE
RAMUCIRUMAB vs RANITIDINE
RAMUCIRUMAB vs RANITIDINE\RANITIDINE